Pricing
Login
Home
Charts
Search
Watchlist
Products

Laurus Labs Ltd

LAURUSLABS
₹2,294.60-0.49%20 Nov 2026
Reports
Pharma CRAMS

Laurus Labs Ltd

LAURUSLABS
₹2,294.60
-0.49%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,23,980Cr
Close
Close Price
₹2,294.60
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
92.45
PS
Price To Sales
15.85
Revenue
Revenue
₹7,823Cr
Rev Gr TTM
Revenue Growth TTM
23.03%
PAT Gr TTM
PAT Growth TTM
96.34%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,1951,4401,1951,2241,4151,7201,5701,6531,7781,8122,0262,206
Growth YoY
Revenue Growth YoY%
-22.64.31.1-0.118.419.531.435.125.75.329.133.4
Expenses
ExpensesCr
1,0141,1981,0241,0451,1301,3001,1871,2501,2981,2991,3881,456
Operating Profit
Operating ProfitCr
181241171178285421382403480512638750
OPM
OPM%
15.216.814.314.620.124.424.424.427.028.331.534.0
Other Income
Other IncomeCr
219359591027612913
Interest Expense
Interest ExpenseCr
515149535856524039404244
Depreciation
DepreciationCr
98102106108106110117120121122124127
PBT
PBTCr
351071823131312224270327361481592
Tax
TaxCr
93265407863767379119155
PAT
PATCr
2575121891234161194253282362437
Growth YoY
PAT Growth YoY%
-87.6-29.8-57.0-54.9260.0210.51,219.3993.4179.320.5124.7125.4
NPM
NPM%
2.15.21.01.46.413.610.311.714.215.617.919.8
EPS
EPS₹
0.41.40.20.41.74.33.03.64.75.26.88.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,1951,4401,1951,2241,4151,7201,5701,6531,7781,8122,0262,206
Growth YoY
Revenue Growth YoY%
-22.64.31.1-0.118.419.531.435.125.75.329.133.4
Expenses
ExpensesCr
1,0141,1981,0241,0451,1301,3001,1871,2501,2981,2991,3881,456
Operating Profit
Operating ProfitCr
181241171178285421382403480512638750
OPM
OPM%
15.216.814.314.620.124.424.424.427.028.331.534.0
Other Income
Other IncomeCr
219359591027612913
Interest Expense
Interest ExpenseCr
515149535856524039404244
Depreciation
DepreciationCr
98102106108106110117120121122124127
PBT
PBTCr
351071823131312224270327361481592
Tax
TaxCr
93265407863767379119155
PAT
PATCr
2575121891234161194253282362437
Growth YoY
PAT Growth YoY%
-87.6-29.8-57.0-54.9260.0210.51,219.3993.4179.320.5124.7125.4
NPM
NPM%
2.15.21.01.46.413.610.311.714.215.617.919.8
EPS
EPS₹
0.41.40.20.41.74.33.03.64.75.26.88.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,7781,9052,0562,2922,8324,8144,9366,0415,0415,5546,8137,823
Growth
Revenue Growth%
34.07.28.011.523.670.02.522.4-16.610.222.723.0
Expenses
ExpensesCr
1,4151,4971,6431,9362,2673,2633,5134,4484,2634,4995,0355,442
Operating Profit
Operating ProfitCr
3624084133565651,5511,4221,5927781,0551,7782,381
OPM
OPM%
20.421.420.115.519.932.228.826.415.419.026.130.4
Other Income
Other IncomeCr
432291662415626755540
Interest Expense
Interest ExpenseCr
11110080889068102165183216171166
Depreciation
DepreciationCr
86106125164187205251324385430480494
PBT
PBTCr
1692342371202941,3011,0841,1092364841,1821,761
Tax
TaxCr
354470263831725131268130292427
PAT
PATCr
134190168942559848327971683548901,334
Growth
PAT Growth%
96.841.9-11.9-44.1172.3285.4-15.4-4.3-78.9110.7151.196.3
NPM
NPM%
7.510.08.24.19.020.416.913.23.36.413.117.1
EPS
EPS₹
21.44.23.21.81.018.415.414.73.06.716.524.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,7781,9052,0562,2922,8324,8144,9366,0415,0415,5546,8137,823
Growth
Revenue Growth%
34.07.28.011.523.670.02.522.4-16.610.222.723.0
Expenses
ExpensesCr
1,4151,4971,6431,9362,2673,2633,5134,4484,2634,4995,0355,442
Operating Profit
Operating ProfitCr
3624084133565651,5511,4221,5927781,0551,7782,381
OPM
OPM%
20.421.420.115.519.932.228.826.415.419.026.130.4
Other Income
Other IncomeCr
432291662415626755540
Interest Expense
Interest ExpenseCr
11110080889068102165183216171166
Depreciation
DepreciationCr
86106125164187205251324385430480494
PBT
PBTCr
1692342371202941,3011,0841,1092364841,1821,761
Tax
TaxCr
354470263831725131268130292427
PAT
PATCr
134190168942559848327971683548901,334
Growth
PAT Growth%
96.841.9-11.9-44.1172.3285.4-15.4-4.3-78.9110.7151.196.3
NPM
NPM%
7.510.08.24.19.020.416.913.23.36.413.117.1
EPS
EPS₹
21.44.23.21.81.018.415.414.73.06.716.524.8
Sales CAGR
1 Year23%
3 Years4%
5 Years7%
TTM23%
EBITDA CAGR
1 Year68%
3 Years4%
5 Years3%
TTM60%
PAT CAGR
1 Year151%
3 Years4%
5 Years-2%
TTM96%
Avg. ROCE
1 Year17%
3 Years11%
5 Years15%
TTM23%
CFO / EBITDA
1 Year91%
3 Years80%
5 Years72%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
16106106106107107107108108108108108
Reserves
ReservesCr
7741,2251,3711,4471,6582,4903,2443,9304,0034,3655,1925,953
Current Liabilities
Current LiabilitiesCr
8841,1211,3071,4241,6922,4572,6812,4323,1123,5403,6353,954
Non Current Liabilities
Non Current LiabilitiesCr
4832022273492886939281,1791,1591,1931,4441,379
Total Liabilities
Total LiabilitiesCr
2,2242,6533,0173,3313,7505,7516,9687,6608,3879,33610,51111,514
Current Assets
Current AssetsCr
1,0031,1401,2481,4631,8123,0753,3453,4623,8354,3324,8295,184
Non Current Assets
Non Current AssetsCr
1,2211,5141,7691,8681,9382,6763,6234,1994,5525,0035,6826,330
Total Assets
Total AssetsCr
2,2242,6533,0173,3313,7505,7516,9687,6608,3879,33610,51111,514
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
16106106106107107107108108108108108
Reserves
ReservesCr
7741,2251,3711,4471,6582,4903,2443,9304,0034,3655,1925,953
Current Liabilities
Current LiabilitiesCr
8841,1211,3071,4241,6922,4572,6812,4323,1123,5403,6353,954
Non Current Liabilities
Non Current LiabilitiesCr
4832022273492886939281,1791,1591,1931,4441,379
Total Liabilities
Total LiabilitiesCr
2,2242,6533,0173,3313,7505,7516,9687,6608,3879,33610,51111,514
Current Assets
Current AssetsCr
1,0031,1401,2481,4631,8123,0753,3453,4623,8354,3324,8295,184
Non Current Assets
Non Current AssetsCr
1,2211,5141,7691,8681,9382,6763,6234,1994,5525,0035,6826,330
Total Assets
Total AssetsCr
2,2242,6533,0173,3313,7505,7516,9687,6608,3879,33610,51111,514

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1823323422983477339119946666021,624
Investing Cash Flow
Investing Cash FlowCr
-312-289-384-253-221-941-914-996-822-682-1,089
Financing Cash Flow
Financing Cash FlowCr
103-5442-45-12825530-2725039-525
Net Cash Flow
Net Cash FlowCr
-27-1010-14727-2993-4110
Free Cash Flow
Free Cash FlowCr
-14455-494412549346-1061560
CFO To PAT
CFO To PAT%
135.7174.5204.3317.5136.174.5109.5124.8395.8169.8182.4
CFO To EBITDA
CFO To EBITDA%
50.281.482.983.661.547.364.062.485.657.091.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1823323422983477339119946666021,624
Investing Cash Flow
Investing Cash FlowCr
-312-289-384-253-221-941-914-996-822-682-1,089
Financing Cash Flow
Financing Cash FlowCr
103-5442-45-12825530-2725039-525
Net Cash Flow
Net Cash FlowCr
-27-1010-14727-2993-4110
Free Cash Flow
Free Cash FlowCr
-14455-494412549346-1061560
CFO To PAT
CFO To PAT%
135.7174.5204.3317.5136.174.5109.5124.8395.8169.8182.4
CFO To EBITDA
CFO To EBITDA%
50.281.482.983.661.547.364.062.485.657.091.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,4505,3344,2553,44919,42831,70715,78221,11433,09953,5461,23,980
Price To Earnings
Price To Earnings
28.631.845.413.519.838.320.0131.592.460.392.5
Price To Sales
Price To Sales
2.92.61.91.24.06.42.64.26.07.915.8
Price To Book
Price To Book
4.13.62.71.97.59.53.95.17.410.120.5
EV To EBITDA
EV To EBITDA
15.215.114.67.813.423.511.230.333.931.553.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
34.537.636.834.638.445.744.341.235.040.446.146.1
OPM
OPM%
20.421.420.115.519.932.228.826.415.419.026.130.4
NPM
NPM%
7.510.08.24.19.020.416.913.23.36.413.117.1
ROCE
ROCE%
16.215.913.38.314.033.623.121.16.39.717.322.5
ROE
ROE%
17.014.311.36.014.537.924.819.74.17.916.822.0
ROA
ROA%
6.07.25.62.86.817.111.910.42.03.88.511.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,4505,3344,2553,44919,42831,70715,78221,11433,09953,5461,23,980
Price To Earnings
Price To Earnings
28.631.845.413.519.838.320.0131.592.460.392.5
Price To Sales
Price To Sales
2.92.61.91.24.06.42.64.26.07.915.8
Price To Book
Price To Book
4.13.62.71.97.59.53.95.17.410.120.5
EV To EBITDA
EV To EBITDA
15.215.114.67.813.423.511.230.333.931.553.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
34.537.636.834.638.445.744.341.235.040.446.146.1
OPM
OPM%
20.421.420.115.519.932.228.826.415.419.026.130.4
NPM
NPM%
7.510.08.24.19.020.416.913.23.36.413.117.1
ROCE
ROCE%
16.215.913.38.314.033.623.121.16.39.717.322.5
ROE
ROE%
17.014.311.36.014.537.924.819.74.17.916.822.0
ROA
ROA%
6.07.25.62.86.817.111.910.42.03.88.511.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,96,8071,23,98053,58938,27931,85931,38526,483
Close PriceClose₹11,180.502,294.60951.051,800.70239.303,833.5020,642.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE88.2292.4587.17101.2271.4758.52
Price To SalesPS24.3515.8526.1916.143.2619.7111.48
RevenueRevenueCr12,1917,8232,0462,3719,7791,5932,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%9.4%45.2%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%-782.0%95.8%88.4%
Market CapitalizationMkt CapCr2,96,8071,23,98053,58938,27931,85931,38526,483
Close PriceClose₹11,180.502,294.60951.051,800.70239.303,833.5020,642.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE88.2292.4587.17101.2271.4758.52
Price To SalesPS24.3515.8526.1916.143.2619.7111.48
RevenueRevenueCr12,1917,8232,0462,3719,7791,5932,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%9.4%45.2%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%-782.0%95.8%88.4%
Interviews